BiotechTube
Home/CASI Pharmaceuticals/James Huang
JH

James Huang

Non-Executive Chairman of the Board

CASI Pharmaceuticals

Roles

Non-Executive Chairman of the BoardatCASI Pharmaceuticals
Executive ChairmanatChime Biologics

Therapeutic Areas

Organ Transplant RejectionAutoimmune DiseasesOncology

CASI Pharmaceuticals Pipeline

DrugIndicationPhase
CID-103 (IV)Antibody-Mediated Rejection (AMR) in Organ TransplantPhase 1/2
CID-103 (IV/SC)Autoimmune Diseases (e.g., Immune Thrombocytopenia)Preclinical
CID-103 (SC)AMR / Autoimmune DiseasesFormulation Development
EVOMELA®Multiple Myeloma (Conditioning)Marketed
FOLOTYN®Peripheral T-Cell LymphomaMarketed

Leadership Team at CASI Pharmaceuticals

DC
David Cory
Chief Executive Officer
AZ
Alex Zukiwski
Chief Medical Officer
JC
Junping Chen
Chief Medical Officer, China
LZ
Larry Zhang
Senior Vice President
IC
Ingrid Choong
Head of Corporate Development
JG
Jim Goldschmidt
Chief Business Officer
HH
Hai Huang
CCO and GM (China)
CW
Chunhua Wang
Chief Operating Officer (China)
KQ
Kun Qian
Global Controller
WG
Wei Gao
General Counsel
View full CASI Pharmaceuticals profile